Skip to main content
. 2019 May 3;10:468. doi: 10.3389/fphar.2019.00468

FIGURE 3.

FIGURE 3

Acute and chronic treatments with E-52862 improved the cognitive deficits induced by MIA injection. (A) Saline or MIA-injected mice treated with vehicle or E-52862 (20 mg/kg, twice daily during 25 days) were evaluated for recognition memory 15 days after the intra-knee injection in the novel object recognition test (NORT). (B) Mice with osteoarthritis pain treated with vehicle showed decreased discrimination index indicating a memory impairment. Acute and chronic treatment with E-52862 reversed the cognitive deficits induced by MIA. (C) Animals revealed similar total exploration times regardless of the surgery or the treatment. Data are expressed as mean ± SEM (n = 6–8 animals per group). p < 0.05, ∗∗∗p < 0.001 vs. MIA-vehicle (1-way ANOVA followed by Fisher least significant difference test). MIA, monosodium iodoacetate; SEM, standard error of the mean.